NSE to list Sudarshan Pharma, Khazanchi Jewellers shares on the Main Board from 27 October
Two companies in India's equity market are moving from the BSE SME platform to the NSE Capital Market Segment, Main Board. The listing takes effect on 27 October 2026, and both shares will be traded in the Normal Market Segment on a mandatory demat basis for all investors.
Highlights
- The equity shares of Sudarshan Pharma Industries Limited and Khazanchi Jewellers Limited will be listed and approved for trading on the NSE Main Board from 27 October 2026.
- Migration from the BSE SME platform to the NSE Main Board can give both companies access to a broader investor base and greater institutional visibility.
- After the new listing, mandatory demat, rolling settlement, and trading in the Normal Market Segment will apply to both shares.
This article was translated from the original. Read the original version by our correspondent here.
Main Board Listing and Trading Arrangements
As stated by the National Stock Exchange of India, NSE India has approved the equity shares of Sudarshan Pharma Industries Limited and Khazanchi Jewellers Limited for listing and trading on the exchange from 27 October 2026. This change follows their migration from the BSE SME platform to the NSE Capital Market Segment, Main Board.Sudarshan Pharma Industries Limited has the trading symbol SUDARSHAN, series EQ, and ISIN code INE00TV01023. Khazanchi Jewellers Limited has the trading symbol KHAZANCHI, series EQ, and ISIN code INE0OWC01011.
Significance for Investors and the Market
Both shares will be traded in the Normal Market Segment, with mandatory demat and rolling settlement arrangements applying to all investors. Moving to the Main Board can generally give companies access to a broader investor base and greater institutional visibility.The move also reflects the progression from SME platforms to larger exchange segments in India's capital markets. It brings trading in the companies' shares in line with the standards of the main market.
Our previous report discussed NSE's warning about alleged illegal trading schemes claiming guaranteed returns and those promoted on Telegram channels. The article explained that individuals/entities offering services such as ‘account handling’ are not registered members or authorised representatives of NSE, and investors who engage with them do not benefit from protections such as the exchange's grievance redressal and dispute resolution mechanisms.